AI assistant
REGENXBIO Inc. — Director's Dealing 2018
Nov 28, 2018
32827_dirs_2018-11-28_486c36ba-62a4-4a2a-a262-b3d90d399f7b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REGENXBIO Inc. (RGNX)
CIK: 0001590877
Period of Report: 2018-11-26
Reporting Person: BESHAR LUKE M (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-26 | Common Stock | M | 1721.00 | $49.45 | Acquired | 1721.00 | Direct |
| 2018-11-26 | Common Stock | S | 1721.00 | $65.00 | Disposed | 0.00 | Direct |
| 2018-11-27 | Common Stock | M | 883.00 | $49.45 | Acquired | 883.00 | Direct |
| 2018-11-27 | Common Stock | M | 4687.00 | $22.00 | Acquired | 5570.00 | Direct |
| 2018-11-27 | Common Stock | M | 6250.00 | $18.85 | Acquired | 11820.00 | Direct |
| 2018-11-27 | Common Stock | M | 6250.00 | $12.74 | Acquired | 18070.00 | Direct |
| 2018-11-27 | Common Stock | M | 716.00 | $3.76 | Acquired | 18786.00 | Direct |
| 2018-11-27 | Common Stock | S | 18786.00 | $65.03 | Disposed | 0.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-11-26 | Stock Option (Right to Buy) | $49.45 | M | 1721.00 | Disposed | 2028-05-25 | Common Stock (1721.00) | Direct |
| 2018-11-27 | Stock Option (Right to Buy) | $49.45 | M | 883.00 | Disposed | 2028-05-25 | Common Stock (883.00) | Direct |
| 2018-11-27 | Stock Option (Right to Buy) | $22.00 | M | 4687.00 | Disposed | 2025-09-16 | Common Stock (4687.00) | Direct |
| 2018-11-27 | Stock Option (Right to Buy) | $18.85 | M | 6250.00 | Disposed | 2027-05-24 | Common Stock (6250.00) | Direct |
| 2018-11-27 | Stock Option (Right to Buy) | $12.74 | M | 6250.00 | Disposed | 2026-06-01 | Common Stock (6250.00) | Direct |
| 2018-11-27 | Stock Option (Right to Buy) | $3.76 | M | 716.00 | Disposed | 2025-05-18 | Common Stock (716.00) | Direct |
Footnotes
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.
F2: This transaction was executed in multiple trades at prices ranging from $65.00 to $65.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: The previously granted option, representing a right to purchase a total of 12,500 shares, became exercisable as follows: the option vests in 12 equal monthly installments following May 25, 2018.
F4: The previously granted option, representing a right to purchase a total of 9,375 shares, became exercisable as follows: the option vested in nine equal monthly installments following September 16, 2015.
F5: The previously granted option, representing a right to purchase a total of 12,500 shares, became exercisable as follows: the option vested in 12 equal monthly installments following May 24, 2017.
F6: The previously granted option, representing a right to purchase a total of 12,500 shares, became exercisable as follows: the option vested in 12 equal monthly installments following June 1, 2016.
F7: The previously granted option, representing a right to purchase a total of 80,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2015, and the balance vested in equal monthly installments over the 24 months thereafter.